Delivery Order SPE2DB20D2002-SPE2DB23FL66R
- Not listed
- This federal contract award, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of Lantus SoloStar 100 unit/ml 3ml, a prescription medication used to treat diabetes. The contract, valued at $1,047.40, is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued by the Defense Logistics Agency (DLA) with a ceiling value of $2,374.40. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medical product used in the treatment of diabetes. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,022.80 and a completion date of May 22, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,810.86 for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on October 12, 2021, with an ultimate completion date of October 13, 2021. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,883.98 contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a medication used to manage diabetes. The award is a delivery order under an Indefinite Delivery Contract (IDC) with a total potential value of $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,548.48, is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a diabetes medication. This is a firm fixed-price delivery order contract with no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,444.24, is for the delivery of Lantus Solostar 100 unit/ml 3ml, a diabetes medication. The contract has a completion date of May 20, 2022 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a specialty medication used to treat diabetes. The $5,308.94 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 2, 2022 with a completion date of May 3, 2022. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,047.65 delivery order contract is for the supply of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract has a completion date of September 6, 2023 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 delivery order contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract has a firm fixed price and is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB23FL66RDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order awarded by the Defense Logistics Agency (DLA) with a ceiling value of $1,607.05. The contract, with a period of performance through September 6, 2023, is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a medication used to treat diabetes. The contract is a firm-fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This delivery order is under that larger IDC contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/5/23 |